Publication | Closed Access

Long-term exposure to sorafenib of liver cancer cells induces resistance with epithelial-to-mesenchymal transition, increased invasion and risk of rebound growth

Hepatocellular CarcinomaMedicineLiver PhysiologyLiver Cancer CellsOncogenic AgentCancer GrowthPathologyCancer BiologyLiver CancerOncologyCell BiologyTumor MicroenvironmentTumor BiologyLong-term ExposureRebound Growth